Investigators compared the risk of cancer onset in patients with lupus nephritis treatedwith calcineurin inhibitors vs ...

Study results are based on Surveillance, Epidemiology, and End Results-Medicare data for 166,581 patients receiving surgery or radiation for localized prostate cancer.

Comparable and high THC-to-CBD ratio products may result in small improvements in pain and increase in common adverse events.

Recommendations include use of ACE-I or ARB to slow CKD progression in patients with hypertension and albuminuria.

Lower number of hospitalizations for any indication and serious adverse events with semaglutide for those with CVD, overweight or obesity.

In 2025, the number of all students enrolled in medical school reached 100,723 — a significant milestone for the future of ...

After controlling for known CV risk factors, all FFR-CT subgroups remained significantly associated with MI, ...

Tirzepatide noninferior to dulaglutide with respect to composite of death from cardiovascular causes, myocardial infarction, ...

44.7 percent of angiotensin receptor blocker initiators were continuously persistent to original drug class at three years.

Investigators sought to evaluate changes in the estimated CV risk of men with prostate cancer after 6 months of hormone therapy using clinical tools established for the general population. A post-hoc ...

Beyond broad recommendations for recurrent kidney stone prevention, clinicians and renal dietitians can create personalized plans.

The US Food and Drug Administration (FDA) has granted 510 (k) clearance for BlueWind Medical, Ltd.’s enhanced Revi® implantable tibial neuromodulator for treatment of urgency urinary incontinence (UUI ...